We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.05B
AUM Growth
+$375M
Cap. Flow
+$361M
Cap. Flow %
34.49%
Top 10 Hldgs %
24.89%
Holding
5,677
New
1,360
Increased
1,920
Reduced
1,136
Closed
1,108

Sector Composition

Rank Sector Weight
1 Financials 6.05%
2 Technology 5.64%
3 Industrials 5.17%
4 Consumer Discretionary 4.28%
5 Healthcare 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFCR icon
2726
Lifecore Biomedical
LFCR
$190M
$11K ﹤0.01%
+946
New +$10.4K
LIND icon
2727
Lindblad Expeditions
LIND
$2.22B
$11K ﹤0.01%
+1,123
New +$11K
MNOV icon
2728
MediciNova
MNOV
$66M
$11K ﹤0.01%
1,508
+955
+173% +$6.91K
MRCY icon
2729
Mercury Systems
MRCY
$6.52B
$11K ﹤0.01%
458
-528
-54% -$11.4K
MRGR icon
2730
ProShares Merger ETF
MRGR
$15.9M
$11K ﹤0.01%
+300
New +$11K
NIC icon
2731
Nicolet Bankshares
NIC
$3.62B
$11K ﹤0.01%
+296
New +$11.4K
NMS icon
2732
Nuveen Minnesota Quality Municipal Income Fund
NMS
$74.2M
$11K ﹤0.01%
660
+93
+16% +$1.53K
NNVC icon
2733
NanoViricides
NNVC
$36.2M
$11K ﹤0.01%
336
+201
+149% +$7.33K
NRIM icon
2734
Northrim BanCorp
NRIM
$587M
$11K ﹤0.01%
+1,660
New +$10.7K
PEX icon
2735
ProShares Global Listed Private Equity ETF
PEX
$11.6M
$11K ﹤0.01%
300
+100
+50% +$3.72K
PGEN icon
2736
Precigen
PGEN
$2.59B
$11K ﹤0.01%
467
+254
+119% +$7.21K
PLG
2737
Platinum Group Metals
PLG
$193M
$11K ﹤0.01%
320
+310
+3,100% +$9.62K
PNRG icon
2738
PrimeEnergy Resources
PNRG
$298M
$11K ﹤0.01%
+184
New +$9.19K
SIF icon
2739
SIFCO Industries
SIF
$176M
$11K ﹤0.01%
1,060
-1,138
-52% -$11.4K
HTO
2740
H2O America
HTO
$2.62B
$11K ﹤0.01%
+267
New +$9.55K
SPEM icon
2741
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
$11K ﹤0.01%
+378
New +$10.2K
TFIN icon
2742
Triumph Financial Inc
TFIN
$1.82B
$11K ﹤0.01%
699
+695
+17,375% +$11K
TRV icon
2743
Travelers Companies
TRV
$80.2B
$11K ﹤0.01%
90
-9,525
-99% -$1.08M
UNH icon
2744
UnitedHealth
UNH
$370B
$11K ﹤0.01%
78
-5,990
-99% -$799K
UVXY icon
2745
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$293M
0
XHR
2746
Xenia Hotels & Resorts
XHR
$1.79B
$11K ﹤0.01%
+674
New +$10.6K
SUNE
2747
SUNation Energy
SUNE
$10.8M
0
ITCI
2748
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$11K ﹤0.01%
293
-137
-32% -$4.92K
PMD
2749
DELISTED
Psychemedics Corporation
PMD
$11K ﹤0.01%
792
+320
+68% +$4.45K
LBAI
2750
DELISTED
Lakeland Bancorp Inc
LBAI
$11K ﹤0.01%
897
-2,396
-73% -$26.7K

Similar funds

Tower Research Capital (TRC)'s Q2 2016 Portfolio in Review

As of Q2 2016, Tower Research Capital (TRC) held 5,677 positions worth $1.05B, up 56% from $672M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $361M of net new capital in Q2 2016, opening 1,360 new positions and adding to 1,920 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.

By sector, the portfolio is most concentrated in Financials at 6.1% of assets, up from 2.5% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $48M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2016 buy was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.
  • Tower Research Capital (TRC) added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q2 2016, an estimated $24.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2016 reduction was iShares Russell 2000 ETF, cutting an estimated $48M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2016, selling an estimated $9.09M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.05B portfolio in Q2 2016.
  • Tower Research Capital (TRC) opened 1,360 new positions and closed 1,108 in Q2 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 56% quarter-over-quarter to $1.05B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.